Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
147,179,178
-
Total 13F shares
-
53,287,730
-
Share change
-
+1,125,462
-
Total reported value
-
$812,631,603
-
Price per share
-
$15.25
-
Number of holders
-
65
-
Value change
-
+$13,608,742
-
Number of buys
-
46
-
Number of sells
-
19
Institutional Holders of Denali Therapeutics Inc. - COMMON STOCK (DNLI) as of Q2 2018
As of 30 Jun 2018 Denali Therapeutics Inc. - COMMON STOCK (DNLI) had 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 53,287,730 shares of stock of the company.
Largest 10 holders included Crestline Management, LP, FMR LLC, BAILLIE GIFFORD & CO, FIL Ltd, Temasek Holdings (Private) Ltd, VANGUARD GROUP INC, BlackRock Inc., BAMCO INC /NY/, Alphabet Inc., and Artal Group S.A..
This table shows 65 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.